Barclays Revises Altria Price Target Higher Citing Sector ReRating Potential Xeris Biopharma XERS Gains 24 as Shares Test Key Resistance at 670 Berkshire Hathaway Under New CEO Greg Abel Dumps Entire Stake in Iconic Fintech Giant BLX Shows Strength Banco Latinoamericano Nears Key Resistance After 2 Gain